Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Standard Essential Patents

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Search results

Featured Matter | November 01, 2022

Represented Plaintiff, a leading pharmaceutical company, in Hatch-Waxman litigation (E.D. Tex.) against five generic drug manufacturers regarding Plaintiff 's glaucoma drug

Featured Matter | November 01, 2022

Represented Plaintiff, a leading pharmaceutical company, in Hatch-Waxman litigation (D.N.J.) against a generic manufacturer regarding Plaintiff 's glaucoma drug

Featured Matter | November 01, 2022

Represented leading supplier of LCD controllers in patent infringement action

Featured Matter | November 01, 2022

Represented leading pharmaceutical company in bench trial in February 2011 in Hatch-Waxman case

Featured Matter | November 01, 2022

Represented leading pharmaceutical company in assertion of patents related to ophthalmic non-steroidal anti-inflammatory drugs

Featured Matter | November 01, 2022

Represented leading pharmaceutical companies in assertion of pharmacological patents

Featured Matter | November 01, 2022

Represented leading fiber optic components company in trade secret litigation

Featured Matter | November 01, 2022

Represented a semiconductor manufacturer in multiple litigations concerning doping of wide band gap semiconductors

Featured Matter | November 01, 2022

Represented a plaintiff at trial and on appeal in Hatch-Waxman action over ANDAs for glaucoma drug

Featured Matter | November 01, 2022

Represented a leading pharmaceutical company at trial and on appeal in multidistrict litigation regarding defendants ' ANDAs for glaucoma drugs

Featured Matter | November 01, 2022

Represented a Fortune 50 consumer electronics manufacturer in three Eastern District of Texas suits accusing smartphones, computers, TVs, and watches of patent infringement

Featured Matter | November 01, 2022

Represented a Fortune 50 consumer electronics manufacturer in patent infringement dispute, related to data processing systems